000 01539 a2200421 4500
005 20250517215610.0
264 0 _c20191125
008 201911s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-018-25754-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHamed, Mohamed
245 0 0 _aA workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson's disease.
_h[electronic resource]
260 _bScientific reports
_c05 2018
300 _a7937 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiparkinson Agents
_xpharmacology
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Regulatory Networks
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPathology, Molecular
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aSmall Molecule Libraries
_xpharmacology
650 0 4 _aTranscription Factors
_xgenetics
650 0 4 _aTranscriptome
650 0 4 _aWorkflow
700 1 _aGladbach, Yvonne
700 1 _aMöller, Steffen
700 1 _aFischer, Sarah
700 1 _aErnst, Mathias
700 1 _aStruckmann, Stephan
700 1 _aStorch, Alexander
700 1 _aFuellen, Georg
773 0 _tScientific reports
_gvol. 8
_gno. 1
_gp. 7937
856 4 0 _uhttps://doi.org/10.1038/s41598-018-25754-5
_zAvailable from publisher's website
999 _c28414524
_d28414524